Can erythropoietin be used to prevent brain damage in cerebral malaria?
Erythropoietin (Epo) modulates the survival of developing erythroid cells and the production of new erythrocytes in the bone marrow and is a key molecule in the adaptation to hypoxia and anaemia. Epo receptors have been found to be widely expressed on non-haematopoietic cells, and Epo has been shown...
Κύριοι συγγραφείς: | Casals-Pascual, C, Idro, R, Picot, S, Roberts, D, Newton, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2009
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Erythropoietin and neuro-protection in African children with cerebral malaria
ανά: Idro, R, κ.ά.
Έκδοση: (2008) -
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.
ανά: Casals-Pascual, C, κ.ά.
Έκδοση: (2008) -
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.
ανά: Idro, R, κ.ά.
Έκδοση: (2010) -
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.
ανά: Idro, R, κ.ά.
Έκδοση: (2005) -
A better biomarker for cerebral malaria: in the eye of the beheld?*.
ανά: Ackerman, H, κ.ά.
Έκδοση: (2012)